FDA Enforcement Class II Terminated

Atrapro Antipruritic Hydrogel, 1.5 oz gel tube, 4 Net wt/ 1.5 oz.. RX only, Professional Sample, Not for Sale. Pre-printed tube: MS31071, Shelf carton: PL51091-08 Atrapro Antipruritic HydroGel is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including radiation dermatitis and atopic dermatitis.

Recall: Z-0890-2013 · Reported March 6, 2013

Enforcement

Recall Number
Z-0890-2013
Event ID
64316
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Oculus Innovative Sciences Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
March 6, 2013
Initiation Date
February 12, 2013
Classification Date
February 26, 2013
Termination Date
November 25, 2013
Address
1129 N Mcdowell Blvd, N/A, Petaluma, CA, 94954-1110, United States

Description

Atrapro Antipruritic Hydrogel, 1.5 oz gel tube, 4 Net wt/ 1.5 oz.. RX only, Professional Sample, Not for Sale. Pre-printed tube: MS31071, Shelf carton: PL51091-08 Atrapro Antipruritic HydroGel is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including radiation dermatitis and atopic dermatitis.

Reason

Out of specification result - stability test failure of free available chlorine (FAC) which functions as a preservative for the hydrogel. The 13 month test result obtained was 4 ppm FAC and the stability specification is >10 ppm FAC.

Code Info

Lot 12A0012, Exp 2/2013; Lot 12A0013, Exp 2/2013: Lot 12A1116, Exp 2.2013; Lot 12A1119, Exp 2/2013; Lot 12B1144, Exp 3/2013; Lot 12B1148, Exp 3/2013; Lot 12C1157, Exp 4/2013; Lot 12E190. Exp 6/2013; Lot 12E194, Exp 6/2013; Lot 12E198, Exp 6/2013; Lot 12E202. Exp 6/2013; Lot 12E208, Exp 6/2013; Lot 12E211, Exp 6/2013.

Distribution

Nationwide Distribution - One distributor in PA

Quantity

56,566 1.5 oz tubes